Breast Cancer Trial, Recruiting NCT05725265 Sponsor: National Taiwan University Hospital Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT05725265
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women aged 20 or older who have had breast cancer on one side of the body, and who had surgery (either breast-conserving surgery or full breast removal) along with removal of lymph nodes from the same side
  • People diagnosed with Stage I or II lymphedema (fluid build-up causing swelling) in one arm, as classified by the International Society of Lymphology
  • People whose affected arm measures at least 2 cm larger in circumference than the unaffected arm at any point along the arm
  • People who are able to attend follow-up appointments over a longer period of time

Who may not be able to join:

  • People whose cancer has spread to other parts of the body (Stage IV/metastatic cancer)
  • People who are pregnant
  • People who have lymphedema in any other limb, whether from birth or caused by another condition
  • People with a history of deep vein thrombosis (blood clots in a vein)
  • People who have a pacemaker
  • People who have artificial joints, implants, or tattoos larger than 4 cm² on the affected arm
  • People who have received low-level laser therapy within the past 3 months
  • People with a Body Mass Index (BMI) above 35
  • People with a condition that causes a high risk of bleeding, such as haemophilia
  • People who are currently on long-term steroid medication taken by mouth or through the whole body

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Chueh-Hung Wu, PHD, Department of Physical Medicine and Rehabilitation, National Taiwan University Hospital, Taipei, Taiwan

Phone: 23123456

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
24 October 2023
Est. completion
31 July 2025

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Circumference discrepancy of bilateral upper arm; Circumference discrepancy of bilateral upper arm; Circumference discrepancy of bilateral upper arm

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov